KBC Group NV - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
KBC Group NV ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1250.0%4,1480.0%0.00%0.0%
Q2 2023$125
-24.7%
4,148
-9.7%
0.00%0.0%
Q1 2023$166
+6.4%
4,5940.0%0.00%0.0%
Q4 2022$156
-99.9%
4,5940.0%0.00%0.0%
Q3 2022$156,000
+17.3%
4,5940.0%0.00%0.0%
Q2 2022$133,000
-58.7%
4,594
-66.2%
0.00%
-50.0%
Q4 2019$322,000
-13.9%
13,5920.0%0.00%
-33.3%
Q3 2019$374,000
-49.8%
13,592
-39.6%
0.00%
-50.0%
Q2 2019$745,000
-5.6%
22,5090.0%0.01%0.0%
Q1 2019$789,000
+68.2%
22,509
+141.9%
0.01%
+50.0%
Q3 2018$469,000
-15.8%
9,3060.0%0.00%
-20.0%
Q2 2018$557,000
-57.1%
9,306
-67.2%
0.01%
-58.3%
Q1 2018$1,299,000
+15.0%
28,3580.0%0.01%
+20.0%
Q4 2017$1,130,000
-0.4%
28,3580.0%0.01%0.0%
Q3 2017$1,134,000
-7.2%
28,3580.0%0.01%
-16.7%
Q2 2017$1,222,00028,3580.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders